Bacterin International Holdings Inc  

(Public, NYSEMKT:BONE)   Watch this stock  
Find more results for NYSEAMEX:BONE
-0.08 (-2.82%)
Jan 23 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 2.76 - 2.80
52 week 2.19 - 14.10
Open 2.76
Vol / Avg. 12,720.00/44,710.00
Mkt cap 18.42M
P/E     -
Div/yield     -
EPS -2.03
Shares 6.68M
Beta 2.35
Inst. own 32%
Mar 16, 2015
Q4 2014 Bacterin International Holdings Inc Earnings Release (Estimated) Add to calendar
Jan 12, 2015
Preliminary Q4 2014 Bacterin International Holdings Inc Earnings Release
Dec 4, 2014
Bacterin International Holdings Inc at LD Micro Conference
Nov 20, 2014
Bacterin International Holdings Inc at Singular Research Best of the Uncovereds Conference
Nov 6, 2014
Q3 2014 Bacterin International Holdings Inc Earnings Call
Nov 5, 2014
Q3 2014 Bacterin International Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -13.79% -38.38%
Operating margin -14.79% -27.24%
EBITD margin - -22.75%
Return on average assets -15.53% -40.06%
Return on average equity - -6505.79%
Employees 128 -
CDP Score - -


600 Cruiser Lane
United States - Map
+1-406-3880480 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bacterin International Holdings, Inc. (Bacterin), formerly K-Kitz, Inc. is a tissue bank and medical device company that designs, processes, manufactures and markets advanced medical products. Its bone graft products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain through facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries. Its acellular dermis scaffolds are utilized in wound care and plastic and reconstructive procedures. Its medical devices division develops coatings for medical devices and custom surgical instruments for use with allografts processed by its biologics division, to produce and distribute OsteoSelect DBM putty, an osteoinductive product. Its biologics products are OsteoSponge, OsteoSponge SC, OsteoWrap, OsteoLock, BacFast HD, OsteoSTX and hMatrix.

Officers and directors

Kent L. Swanson Independent Acting Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Robert Di Silvio President
Age: 61
Bio & Compensation  - Reuters
Daniel S. Goldberger Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
John P. Gandolfo Chief Financial Officer
Age: 53
Bio & Compensation  - Reuters
Darrel Lee Holmes Chief Operating Officer
Age: 60
Bio & Compensation  - Reuters
Gregory Juda Ph.D. Chief Scientific Officer
Age: 38
Bio & Compensation  - Reuters
David E. Goodman M.D. Director
Age: 58
Bio & Compensation  - Reuters
John Deedrick Independent Director
Age: 51
Bio & Compensation  - Reuters
Michael A. Lopach CPA Independent Director
Age: 65
Bio & Compensation  - Reuters
Jon M. Wickwire Independent Director
Age: 70
Bio & Compensation  - Reuters